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Abstract
Small‐quantity lipid‐based nutrient supplements (SQ‐LNS) have been studied in efficacy
and effectiveness trials, but little is known about how parents perceive the products and
their effects. In a randomised trial in Ghana, efficacy of SQ‐LNS provided to women dur-
ing pregnancy and the first 6 months postpartum and to their children from 6 to
18 months of age was assessed by comparison with iron‐folic acid (IFA) capsules and
multiple micronutrient (MMN) capsules provided to women. In a follow‐up study con-
ducted when the index children from the original trial were between 4 and 6 years of
age, we used survey‐based methods to assess retrospective and current parental per-
ceptions of nutrient supplements generally and of SQ‐LNS and their effects compared
with perceptions IFA andMMN capsules.Most parents perceived that the assigned sup-
plements (SQ‐LNS, IFA, or MMN) positively impacted the mother during pregnancy
(approximately 89% of both mothers and fathers) and during lactation (84% of mothers
and 86% of fathers). Almost all (≥90%) of mothers and fathers perceived that the
assigned supplement positively impacted the index child and expected continued posi-
tive impacts on the child's health and human capital into the future. A smaller percentage
of parents perceived negative impacts of the supplements (7%–17% of mothers and
4%–12%of fathers). Perceptions of positive impacts and of negative impacts did not dif-
fer by intervention group. The results suggest that similar populations would likely be
receptive to programs to deliver SQ‐LNS or micronutrient capsules.
KEYWORDS
child nutrition, Ghana, maternal nutrition, multiple micronutrients, perceptions, small‐quantity lipid‐
based nutrient supplements
1 | INTRODUCTION
Small‐quantity lipid‐based nutrient supplements (SQ‐LNS) were
designed to prevent undernutrition during the critical “first 1,000 days”,
from conception to age two. In addition to a range of micronutrients,
SQ‐LNS also enrich the diets of pregnant and lactating women and of
young children with some key macronutrients, including essential fatty
acids. Over the past decade, studies in sub‐Saharan Africa
(Adu‐Afarwuah et al., 2016; Adu‐Afarwuah et al., 2015;
Adu‐Afarwuah, Lartey, Zeilani, & Dewey, 2011; Ashorn, Alho, Ashorn,
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Cheung, Dewey, Gondwe, et al., 2015a; Ashorn, Alho, Ashorn, Cheung,
Dewey, Harjunmaa, et al., 2015b; U. Ashorn et al., 2015c; Hess et al.,
2015; Klevor et al., 2016; Maleta et al., 2015; Phuka et al., 2008), South
Asia (Dewey et al., 2017; Mridha et al., 2016), and the Caribbean
(Iannotti et al., 2014) have provided evidence on the acceptability (i.e.,
willingness to consume the product and/or feed it to an infant, opinions
about sensory characteristics like colour, odour, and taste, etc.), effi-
cacy, and effectiveness of SQ‐LNS (~20 g/day). However, very little is
known about participant perceptions of interventions that provide
SQ‐LNS and perceptions of the effects of SQ‐LNS.
Participant perceptions are an important component of the overall
evidence base on SQ‐LNS and other pre and postnatal nutrient supple-
ments. In particular, understanding how parents perceive supplements
and interventions that provide them can help inform future efforts to
scale‐up the delivery of SQ‐LNS or other point‐of‐use micronutrient
fortified products. Also, there is evidence that parents' investments in
their child's health and human capital can be influenced by an early‐life
intervention that parents perceived had a positive effect on their child's
health or cognitive development (Almond & Mazumder, 2013). In Tan-
zania, for example, children with prenatal exposure to a maternal iodine
supplementation program were breastfed longer and were more likely
to be vaccinated than unexposed children (Adhvaryu & Nyshadham,
2016). Knowledge about parental perceptions, then, may be important
for the design andmanagement of programs to deliver SQ‐LNS or other
micronutrient supplements and for understanding the potential for sup-
plementation to influence parents' investments in their children.
BetweenDecember 2009 andMarch 2014, the International Lipid‐
Based Nutrient Supplement (iLiNS) Project implemented a randomised
controlled trial in Ghana to test the efficacy of SQ‐LNS. The trial pro-
vided SQ‐LNS to mothers during pregnancy and the first 6 months
postpartum and to their infants from 6 to 18 months of age. SQ‐LNS
provided to mothers during pregnancy increased infant birth size, par-
ticularly among primiparous mothers (Adu‐Afarwuah et al., 2015), and
comprehensive SQ‐LNS to mothers during pregnancy and the first
6 months postpartum and to their infants from 6 to 18 months of age
increased mean attained length at 18 months (Adu‐Afarwuah et al.,
2016). Child developmental outcomes at 18 months did not differ
between intervention groups (Prado et al., 2016).
In this paper, using survey‐based quantitative data collected during a
follow‐up study several years after the trial, we first describe mothers'
and fathers' perceptions of maternal supplementation during pregnancy
and lactation and perceptions of child supplementation during early
childhood. This initial descriptive analysis characterizes parents' percep-
tions of maternal and child nutrient supplementation in a general sense
rather than perceptions of specific supplements. Then, leveraging the
trial's randomised design, we report on the effects of the intervention
on parents' retrospective and current perceptions of maternal and child
supplementation with SQ‐LNS vis‐à‐vis their perceptions of the effects
of maternal supplementation with iron‐folic acid (IFA) or
multiple micronutrient (MMN) capsules. Finally, we describe mothers'
retrospective perceptions of their children's reactions to consuming
SQ‐LNS. Because these perceptions data were collected several years
after the intervention concluded, parents had time to observe how the
intervention affected them and their child in both the short‐ and
medium‐ terms and also to consider their perceptions of the intervention
from amore detached standpoint. As such, the findings here complement
assessments of perceptions performed during the intervention itself.
2 | METHODS
2.1 | Main trial
The main trial was conducted in several adjoining semiurban communi-
ties in the Yilo Krobo and Lower Manya Krobo districts in the Eastern
Region of Ghana that were situated along a busy commercial corridor.
Households in the area earned income largely via nonfarm sources,
such as engagement in petty trade, the operation of shops and kiosks,
and the provision of skills and services. In 2014, 17% of children under
five in the Eastern Region were stunted (Ghana Statistical Service,
Ghana Health Service, & ICF International, 2015).
From December 2009 through December 2011, pregnant women
were recruited into the main trial on a rolling basis during routine visits
to one of four main health facilities in the area. Eligible women who
provided informed consent were individually randomised into one of
the trial's three equally‐sized intervention groups: (a) daily IFA capsules
during pregnancy, a component of the standard of antenatal care in
Ghana, a low‐dose calcium placebo capsule for the first 6 months post-
partum, and no infant supplementation (b) daily MMN capsules during
pregnancy and the first 6 months postpartum and no infant supple-
mentation, or (c) 20 g/day SQ‐LNS during pregnancy and the first
6 months postpartum followed by 20 g/day SQ‐LNS for the infant
from 6 to 18 months of age. The IFA and MMN capsules were identical
in appearance, and mothers in the IFA and MMN groups were blinded
to which capsule they received. Because the micronutrients in SQ‐LNS
were delivered in a food‐based paste, it was not possible to blind the
lipid‐based nutrient supplements (LNS) group. The nutrient content
of each of the capsules and of the SQ‐LNS product for pregnant and
lactating women and the SQ‐LNS product for children are available in
Table S1.
Key messages
• There is limited evidence on how parents perceive small‐
quantity lipid‐based nutrient supplements and their
effects.
• In a follow‐up study in Ghana, most parents perceived
that the assigned supplements (iron‐folic acid capsules
for mothers, multiple micronutrient capsules for
mothers, or small‐quantity lipid‐based nutrient
supplements for mothers and their infants) positively
impacted both the mother and her child, whereas
perceptions of negative effects were uncommon.
• Perceptions did not differ by intervention group.
• Accounting for both positive and negative perceptions
of nutrient supplements in the design and management
of programs to deliver them may help promote
acceptability and compliance in similar populations.
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At enrolment, trained nurses told all women that because women
need more vitamins and minerals when they are pregnant, they would
be receiving a supplement. Nurses also gave women instructions for tak-
ing their assigned supplement and a standardminimum nutritionmessage
reminding them to continue to consume nutritious foods whenever pos-
sible. During pregnancy, all women were visited by project staff every
2 weeks to deliver supplements and collect data on maternal morbidity
and study adherence. After the birth of the infant (hereafter index child),
home visits occurred weekly. When the index children were 6 months of
age, all mothers were instructed on the importance of continuing to
breastfeed and were provided with a minimum nutrition message
reminding them to give their infants nutritious foods. The text of the
instructional and minimum nutrition messages is available in Supplemen-
tal Methods 1.
The scheduled frequency of contact between study staff and the
women and infants enrolled in the study as well as the content of those
visits were, by design, uniform across intervention groups. However,
some women received additional unscheduled visits to address difficul-
ties with taking their assigned supplement or difficulty feeding their
infants. In cases of the former, nurses workedwith thewomen to identify
the problem and suggest a solution (e.g., take the supplement at a differ-
ent time of day, mix the supplement with a different food, etc.). In cases
of the latter, nurses advised mothers on ways to encourage their infants
to eat and reiterated the standard minimum nutrition message, noting
that it can take time for infants to accept new foods.
2.2 | Follow‐up
When the index children were between 4 and 6 years of age, we con-
ducted a follow‐up study with the primary objective of assessing the
longer term effects of SQ‐LNS on child growth and development. Sev-
eral months before the start of follow‐up data collection, we
attempted to reestablish contact with all households from the main
trial, excluding misdiagnosed pregnancies (n = 5) and miscarriages
(n = 37), to inform them about the follow‐up and to update their con-
tact information. At the beginning of the follow‐up data collection
period, which spanned January 2016 to December 2016, we visited
households to provide details about the follow‐up, obtain informed
consent, and collect socioeconomic data.
As a component of the follow‐up data collection activities, we
used survey‐based methods to collect retrospective and current per-
ceptions data from mothers and, separately, from fathers. Survey‐
based methods were used to allow for statistical comparisons of
perceptions between the intervention groups. The first set of ques-
tions asked mothers and fathers about their current perceptions of
nutrient supplements in general (i.e., not supplements specific to the
intervention). The next set of questions pertained specifically to the
supplements received during the intervention. To ensure that parents
recognized that the questions were meant to elicit both positive and
negative perceptions of the assigned supplements and their effects,
data collectors prefaced that set of questions with the following:
“Now we would like to ask you some questions about your experi-
ences regarding the iLiNS project. We are interested in both positive
and negative experiences. Please think back to when you were a par-
ticipant in this project and feel free to share with us whatever your
experiences were, whether good or bad. Remember, it's ok to share
both.” Then, mothers and fathers were shown a picture of SQ‐LNS
and a picture of a capsule and asked to recall which supplement the
mother received during the intervention. This was followed by a series
of questions that assessed parents' retrospective and current percep-
tions of the effects of the assigned supplements (SQ‐LNS, IFA cap-
sules, or MMN capsules) on the mother, the index child, and other
household members. These questions were posed to all mothers and
fathers regardless of whether or not they correctly recalled which sup-
plement was received during the intervention. A final set of questions,
posed only to mothers in the LNS group who correctly recalled that
their child received SQ‐LNS during the intervention, were specific to
maternal perceptions of experiences related to child consumption of
SQ‐LNS.
Almost all survey questions were open ended, and data collectors
were instructed to record multiple responses if a respondent provided
more than one answer to a question. Two sets of questions had
prespecified response options that were read out to respondents. The first
was a set of questions askingmothers and fathers to project into the future
and think about their expectations of the supplement's potential impact on
the index child's ability to dowell in school, his/her cognitive development,
his/her ability to do physical work, and his/her ability to earn money. Par-
ents were asked to choose one response among “no impact”, “positive
impact”, or “negative impact”. The second was a question posed only to
mothers in the LNS group asking them to recall how frequently (less than
once a week, about once a week, a few times a week, or every day) their
child asked for SQ‐LNS in the fewweeks following the end of the interven-
tion. All survey questions are available in Supplemental Methods 2.
The follow‐up study was approved by the ethics committees of
the University of California, Davis, the Ghana Health Service, and the
University of Ghana, College of Basic and Applied Sciences. The main
trial was registered at clinicaltrials.gov as NCT00970866.
2.3 | Sample size and statistical methods
The original sample size for the main trial was 1,320 women, with an
equal number of women per group as described in Adu‐Afarwuah
et al. (2015). At follow‐up, we attempted to include all mothers and
fathers from the main trial, excluding misdiagnosed pregnancies, mis-
carriages, and, for the follow‐up sample of mothers, maternal deaths.
To evaluate the effect of the provision of SQ‐LNS on parental per-
ceptions, we combined the IFA and MMN capsule groups into one
group (capsules group) and compared them with the LNS group. The
randomised design of the main trial ensured balance among the inter-
vention groups. However, attrition in the follow‐up study raised the
potential for nonrandom imbalance between groups at follow‐up. We
evaluated the extent of this potential issue in our data in several ways.
First, we used logistic regression to compare attrition between the
intervention groups. We also evaluated differences in baseline charac-
teristics between the sample that was captured at follow‐up and those
who were lost to follow‐up using logistic (for dichotomous variables)
and ordinary least squares (OLS) (for continuous variables) regression.
Finally, we used logistic and OLS regression to evaluate balance in
baseline characteristics in the follow‐up sample between the LNS
group and the capsules group.
ADAMS ET AL. 3 of 11
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As noted, most survey questions were open ended, and data col-
lectors were instructed to record multiple responses. We dichotomized
each response, and, for perceptions analysed by group, we defined a
“gatekeeper” outcome in order to limit the number of hypothesis tests
(a total of 13 gatekeeper outcomes were analysed by group for
mothers and for fathers). If there was a significant difference by group
for the gatekeeper outcome, we proceeded to that perception's
suboutcomes. For example, if the survey question was “Can you share
with me any negative impact on you yourself that was due to the
Nkatepa [the local name for SQ‐LNS]/capsule that you took during
pregnancy?,” we created a dichotomous variable to indicate whether
the respondent reported any negative impacts. Here, the gatekeeper
was “The assigned supplement had a negative impact on the mother
during pregnancy.” If there was a significant difference in the propor-
tion with this perception between groups, we proceeded to evaluate
whether there were group differences in specific negative impacts that
were mentioned by respondents. For gatekeeper outcomes, responses
of “does not know” were coded as missing.
The main analyses were conducted in Stata 14 (StataCorp) by inten-
tion‐to‐treat using logistic regression for dichotomous outcomes and
ordered logit models for ordered outcomes. Hypothesis tests were two
sided at the 5% level of significance. Mothers' and fathers' perceptions
were analysed separately. All models were estimated twice, first adjusting
for index child age at the time of the perceptions interview and thenwith
age plus an additional set of prespecified baseline covariates. Baseline
covariates were included in the fully adjusted models if they were associ-
ated with the outcome at the 10% level of significance in a bivariate anal-
ysis or if they were significantly different in the follow‐up sample
compared with the lost to follow‐up sample. For the mothers' percep-
tions analyses, prespecified covariates were index child gender, index
child birth order, maternal height, maternal age, maternal education, gen-
der of head of household, and household electrification. Prespecified
covariates for the analyses of fathers' perceptions were index child gen-
der, index child birth order, mother's education, father's education, gen-
der of head of household, and household electrification. For outcomes
with extremely low variation in responses (i.e., ≥95% of all responses
were the same), we reported percentages by group but did not analyse
these outcomes for differences between groups.
Perceptions of use of supplements in general (i.e., not supplements
specific to the intervention) were summarized over all mothers and
over all fathers and were not analysed by intervention group. For these
general perceptions and for maternal perceptions of experiences
related to child consumption of SQ‐LNS (collected only from mothers
who correctly recalled that their child received SQ‐LNS), responses
to open‐ended questions were reported if they were mentioned by
at least 5% of either mothers or fathers. Questions that were specific
to child supplementation were skipped if the index child had died.
3 | RESULTS
3.1 | Attrition and balance
Of the 1,320mothers whowere originally randomised into the main trial,
we attempted to recontact 1,273 mothers. Misdiagnosed pregnancies
(n = 5), miscarriages (n = 37), and maternal deaths (n = 5) were excluded
from follow‐up. We successfully recontacted and interviewed 981
mothers (rate of successful follow‐up of 77.1%). Based on the original
sample of 1,320 mothers, the overall rate of attrition was 25.7%. Overall
attrition was 23.9% in the LNS group and 26.6% in the capsules group
and did not differ between groups (p = .29).
We attempted to follow up with 1,278 fathers, excluding fathers of
misdiagnosed pregnancies (n = 5) and miscarriages (n = 37). Primarily
because fathers were difficult to reach at home during the day, hadmoved
out of the study area and could not be located, or had separated from the
mother since the main trial, the number of fathers who were successfully
interviewed (n = 296) waswell below the number of fathers we attempted
to interview. The success rate for paternal interviews, based on the origi-
nally randomised sample of 1,320, was 23.6% in the LNS group and 21.8%
in the capsules group (p = .46). Given these low success rates, the fathers
who were interviewed may represent a biased sample of all fathers and
therefore all analyses of fathers' perceptions are considered exploratory.
Table 1 presents a comparison of selected baseline and index child
characteristics between the maternal sample for the follow‐up and
those lost to follow‐up. Compared with those lost to follow‐up, the
average age of the index children at the beginning of follow‐up data
collection was slightly younger among mothers in the follow‐up
TABLE 1 Characteristics of participants in the maternal follow‐up compared with those lost to follow‐up
Follow‐up sample Lost to follow‐up sample
Variable N Mean ± SD N Mean ± SD p value
Index child age at start of follow‐up data collection (year) 980 4.6 ± 0.6 267 4.7 ± 0.6 .03
Index child male (%) 981 49 267 51 .52
Maternal parity at birth of index child (n) 981 2.3 ± 1.3 339 2.1 ± 1.2 .01
Maternal age (year) 981 27.0 ± 5.4 339 26.0 ± 5.7 .01
Maternal education (year) 978 7.4 ± 3.6 321 7.5 ± 3.9 .89
Maternal height (m) 980 1.59 ± 0.06 336 1.58 ± 0.06 .06
Head of household female (%) 976 26 319 34 .01
Household has electricity (%) 978 86 321 82 .12
Index child birth weight (g) 929 2996 ± 425 229 2926 ± 455 .03
Index child LAZ at 18 months 876 −0.82 ± 1.0 168 −0.91 ± 1.0 .31
Note: Values are mean ± standard deviation for continuous variables and percentage for dichotomous variables. p values for tests of difference in mean/percentage
between follow‐up and lost to follow‐up samples from logistic (for dichotomous variables) andOLS (for continuous variables) regressions. LAZ= length‐for‐age z‐score.
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sample. Mothers in the follow‐up sample were also approximately a
year and a half older, on average, had slightly more pregnancies prior
to the index child, and were less likely to have resided in female‐
headed households at baseline. The average birth weight of index chil-
dren of mothers in the follow‐up sample was slightly higher than in the
lost to follow‐up sample. Among mothers in the follow‐up sample,
baseline and index child characteristics were balanced between the
LNS and capsules groups (Table S2).
3.2 | Perceptions of use of supplements
Perceptions of the use of supplements in general (i.e., not supplements
specific to the intervention) are presented for all mothers and fathers in
Table 2. The most common reasons mothers gave for why women might
use any supplements during pregnancywere “to getmore blood”, which is
how Ghanaians typically refer to the prevention of anaemia (mentioned
by 57.9% of mothers), “for the growth of the baby” (53.2%), “for good
energy or health” (47.1%), and “to increase maternal appetite” (23.3%).
“To get more blood”was also the most common reason cited by mothers
forwhywomenmight use supplements during lactation (45.4%).Mothers
alsomentioned that supplementsmight be taken during lactation tomake
the mother stronger (37.4%), for the baby's health (27.2%), to increase
maternal appetite (24.4%), and to increase breastmilk production
(16.1%). Fathers had very similar perceptions about why women might
use supplements during pregnancy and lactation.
When asked why a woman might not use supplements during
pregnancy, the reasons mothers mentioned included nausea and
vomiting (mentioned by 24.2% of mothers), laziness (17.0%), no need
(16.7%), the supplements are too costly (6.3%), the supplements cause
dizziness (5.6%), and a dislike for medicine and/or supplements (5.3%).
Some mothers said they did not know (16.7%), and others said there
was no special or particular reason why pregnant women might not
use supplements (11.0%). Mothers most commonly cited “no need”
as a reason a woman might not use supplements during lactation
(30.3%), while 25.7% said they did not know, 20.3% said there was
no particular reason, and 9.0% mentioned cost. Again, fathers' percep-
tions were very similar to maternal perceptions.
When asked why parents might give supplements to their young
children, 56.4% of mothers said “to increase the child's appetite,” and
47.3% said “to promote good health.” Other reasons mentioned
included to gain weight (13.7%), to help the child become more active
(11%), for growth (10.6%), to “get more blood” (9.3%), and to prevent
undernutrition (7.6%). Fathers also perceived that parents might give
their young children supplements to promote good health (54.5% of
fathers) and to increase the child's appetite (44.8%). Mothers said that
parents might not give their young children supplements because there
was “no need” (37.4%), for no special or particular reason (26.4%), or
because they were too costly (15.2%). Fathers also most frequently
mentioned that parents might not give their young children supple-
ments because there was “no need” (35.1%).
Finally, mothers and fathers were asked to recall which supple-
ment they received during the intervention. Among mothers in the
LNS group, almost all (98.5%) correctly recalled that they had received
SQ‐LNS, while 1.2% thought they had received capsules and one
respondent could not remember. Among mothers in the IFA or MMN
TABLE 2 Maternal and paternal perceptions of use of supplements
Mothers Fathers
N Percent1 N Percent1
(1) Reasons a woman might use
supplements during pregnancy
980 295
To get more blood 57.9 50.3
For growth of the baby 53.2 53.2
For good health/energy 47.1 47.1
To increase appetite 23.3 19.7
To gain weight 4.5 6.1
(2) Reasons a woman might use
supplements during lactation
978 295
To get more blood 45.4 53.2
To make mother stronger 37.4 29.5
For baby's health 27.2 31.9
To increase appetite 24.4 17.3
For more breastmilk 16.1 19.0
Does not know 5.2 5.1
No special reason 5.1 6.4
(3) Reasons a woman might not use
supplements during pregnancy
979 296
Nausea/vomiting 24.2 19.6
Laziness 17.0 14.2
Does not know 16.9 12.8
No need 16.7 19.6
No special reason 11.0 13.5
Too costly 6.3 8.1
Dizziness 5.6 4.1
Dislikes medicine/supplements 5.3 5.4
Lack of knowledge/ignorance 1.0 6.1
(4) Reasons a woman might not use
supplements during lactation
975 295
No need 30.3 31.5
Does not know 25.7 22.0
No special reason 20.3 18.6
Too costly 9.0 8.1
Lack of knowledge/ignorance 0.4 5.8
(5) Reasons parents might give children
supplements between the ages of
6 months and 2 years
956 288
To increase appetite 56.4 44.8
For good health 47.3 54.5
To gain weight 13.7 14.6
To be more active 11.0 6.9
For growth 10.6 7.6
To get more blood 9.3 6.6
To prevent undernutrition 7.6 4.2
Does not know 6.4 4.9
No special reason 4.7 9.0
(6) Reasons parents might not give
children supplements between the
ages of 6 months and 2 years
958 288
No need 37.4 35.1
No special reason 26.4 21.2
Too costly 15.2 11.8
(Continues)
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capsules groups, 94.0% correctly remembered that they had received
capsules, 4.0% thought they had received SQ‐LNS, and 2.0% could
not remember. Fathers, particularly those whose wives were in the
capsules group, were less likely to remember which supplement the
mother had received. If the mother was in the LNS group, 76.0% of
fathers remembered that she had received SQ‐LNS, 2.9% thought
she had received capsules, and 21.2% could not remember. If the
mother had received capsules, 43.8% of fathers correctly recalled that
she had received capsules, 3.1% thought she had received SQ‐LNS,
and over half (53.1%) could not remember.
3.3 | Perceptions of effects of the intervention
Table 3 shows the predicted percentages of mothers who agreed with
the various perceptions of the effects of the intervention. Overall,
most mothers perceived that the assigned supplements (SQ‐LNS,
IFA, or MMN) positively impacted them during pregnancy (89% of
mothers) and during lactation (84%), and 90% perceived a positive
impact on the index child. Mothers' perceptions of negative impacts
were rarer; 17% of mothers perceived that the assigned supplement
negatively impacted the mother during pregnancy, 7% perceived neg-
ative impacts during lactation, and 7% perceived negative impacts on
the index child. With the exception of a marginally significantly higher
percentage of mothers in the capsules group reporting that the
assigned supplement had a negative impact on the index child (7.9%
vs. 4.9%, p= .09), there were no significant differences between groups
in any of the perceptions. When estimated using the fully adjusted
models, these results did not change.
The most commonly cited positive impacts of the assigned supple-
ment on the mother during pregnancy were improved health (66% of
mothers), feeling more hungry (31%), and increased strength or sta-
mina (23%). Commonly cited positive impacts during lactation were
improved health (63%), feeling more hungry (20%), and producing
more breastmilk (9%). The most commonly cited negative effects
during pregnancy were nausea and vomiting (mentioned by 10% of
mothers), while the most commonly noted negative impact during lac-
tation was an increased appetite (2%).
Approximately 80% of mothers indicated they believed it was
acceptable for children between the ages of 6 months and 2 years to
be given supplements. The most commonly mentioned positive effects
of the assigned supplement on the index child were that the child was
in good health (mentioned by 50% of mothers), that the child was very
active (49%), that the child was learning fast (41%), and that the child
was growing well (18%). The most commonly reported negative impact
was that the child was hyperactive (mentioned by 3% of mothers).
When asked how the current health of the index child compared
with other children in the household and other children of similar
age, over 90% of mothers indicated that there were differences in
the index child's health. While not all differences cited were positive
(for example, several mothers mentioned that the child was not grow-
ing well or not growing tall), 58% mentioned that the index child was
more active than other children, 55% felt the index child was in better
health, 44% said the index child was more intelligent than other chil-
dren, and 9% said the child had healthier skin. When mothers were also
asked about their expectations for the supplement's potential impact
on the index child's future, over 90% of all mothers, in both interven-
tion groups, expected that the assigned supplement would have a pos-
itive impact on the index child's ability to do well in school, her or his
cognitive development, her or his ability to do physical work, and her
or his ability to earn money.
Finally, when asked to recall whether their participation and the
participation of the index child in the intervention had an impact on
other household members, approximately 56% of mothers in both
groups reported that other household members were impacted by
the intervention. The most commonly reported impact was that other
household members benefited from the incentives provided by the
project, which included things like soap, biscuits, and drinks (44%).
With few exceptions, fathers' perceptions were similar to
mothers'. There were no significant intervention group differences in
paternal perceptions of the effects of the intervention (Table 4). These
results did not change in the fully adjusted models. Like mothers, most
fathers perceived a positive impact of the assigned supplement on the
mother during pregnancy (approximately 89% of fathers) and lactation
(86%), and 97% perceived a positive impact on the index child. Approx-
imately 12% of fathers' perceived negative impacts on the mother dur-
ing pregnancy, 4% perceived negative impacts on the mother during
lactation, and 9% perceived negative impacts on the index child. While
approximately 80% of mothers said they felt it was acceptable for chil-
dren between the ages of 6 months and 2 years to be given supple-
ments, 68% of fathers felt that it was acceptable. The most
commonly cited positive impacts reported by fathers were that the
child was very active (49% of fathers), was in good health (45%), was
learning fast (42%), and was growing well (15%).
Table S3 shows crosstabulations of the perceived effects of the
intervention among households in which both the mother and father
were successfully surveyed (N = 281). The crosstabulations show that,
in general, the perceptions of mothers and fathers in the same house-
hold were mostly in agreement. The two perceptions with the highest
percentage of disagreement were whether or not the parent felt it was
TABLE 2 (Continued)
Mothers Fathers
N Percent1 N Percent1
Does not know 9.7 12.9
Advice from others 2.1 7.3
(7) LNS group: Accuracy of recollection
of supplement mother received
during the intervention
336 104
Correct recollection 98.5 76.0
Incorrect recollection 1.2 2.9
Does not know/remember 0.3 21.2
(8) Capsules group: Accuracy of
recollection of supplement mother
received during the intervention
647 192
Correct recollection 94.0 43.8
Incorrect recollection 4.0 3.1
Does not know/remember 2.0 53.1
Note: LNS = lipid‐based nutrient supplements.
1Values are percentage of respondents who mentioned the specific
response. Specific responses reported when mentioned by ≥5% of either
mothers or fathers.
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acceptable for children aged 6 months and 2 years to be given supple-
ments (approximately 60% of mother and father pairs disagreed, with
more mothers indicating it was acceptable while their husbands did
not) and whether the parent perceived that the intervention had an
impact on other household members (almost half of mother and father
pairs disagreed, with fathers more commonly perceiving impacts on
other household members while the mothers did not).
3.4 | Maternal perceptions related to child
consumption of SQ‐LNS
Among mothers in the LNS group, when shown a sachet of SQ‐LNS
and asked whether or not the index child received any of the product
around the time they turned 6 months of age, 8.7% incorrectly recalled
that the index child did not receive SQ‐LNS, and 7.5% could not
remember. The descriptive statistics in Table 5 present maternal per-
ceptions related to the index child's consumption of SQ‐LNS among
the 83.4% of mothers who recalled that their child received SQ‐LNS.
A majority of these mothers (61.7%) said that there was never a
time during the intervention period when they did not give the index
child SQ‐LNS. Of the 35.2% of mothers who said there were times
they did not give the index child SQ‐LNS, the most common reasons
were because the mother forgot (40.2%), the child refused food
(23.5%), the child refused food specifically mixed with SQ‐LNS
(22.6%), and travel (12.8%).
When asked about the index child's reaction when the child
stopped receiving SQ‐LNS at the end of the intervention, most
mothers reported that the child was indifferent (75.2%), while 17.2%
reported that the child asked for SQ‐LNS, and 5.9% could not recall.
Among those whose child asked for SQ‐LNS, 18.0% reported that
the index child asked for it every day for the first few weeks after sup-
plementation, 20.0% said that the index child requested it a few times
a week, 32.0% reported requests approximately once per week, and
26.0% reported that the child requested SQ‐LNS less than once per
week.
Most mothers (82.8%) said they did not give the index child any-
thing to replace SQ‐LNS at the end of the intervention. Of the 15.9%
TABLE 3 Maternal perceptions by intervention group
Perception
LNS group Capsules Group1
N
Predicted percentage
(95% CI)2 N
Predicted percentage
(95% CI)2 p value
1) The assigned supplement had a positive impact on the mother during pregnancy 323 87.4 (83.7, 91.0) 619 89.2 (86.7, 91.6) .413
2) The assigned supplement had a positive impact on the mother during lactation 311 83.5 (79.7, 87.6) 608 85.1 (82.3, 88.0) .523
3) The assigned supplement had a negative impact on the mother during pregnancy 332 15.7 (11.7, 19.6) 640 17.0 (14.1, 19.9) .593
4) The assigned supplement had a negative impact on the mother during lactation 332 6.0 (3.4, 8.5) 638 7.8 (5.7, 9.9) .293
5) It is acceptable for children aged 6 months and 2 years to be given supplements 307 77.0 (72.2, 81.7) 615 81.2 (78.1, 84.3) .143
6) The assigned supplement had a positive impact on the index child 306 91.2 (88.0, 94.4) 605 89.3 (86.8, 91.7) .363
7) The assigned supplement had a negative impact on the index child 332 4.9 (2.5, 7.2) 640 7.9 (5.7, 10.0) .093
8) There are differences in the health of the index child compared with other children 305 93.9 (91.2, 96.6) 586 92.4 (90.2, 94.5) .393
9) Supplement's role in child's cognitive development in the future 316 612 IV4
Negative impact 1.6 1.3
No impact 1.9 1.5
Positive impact 96.5 97.2
10) Supplement's role in child's performance in school in the future 303 590 0.195
Negative impact 3.6 2.0
No impact 5.0 4.2
Positive impact 91.4 93.7
11) Supplement's role in child's ability to do physical work in the future 314 617 IV4
Negative impact 2.2 1.9
No impact 1.6 2.1
Positive impact 96.2 96.0
12) Supplement's role in child's ability to earn money in the future 308 595 IV4
Negative impact 2.0 1.0
No impact 1.3 1.2
Positive impact 96.7 97.8
13) The intervention had an impact on other household members 335 56.4 (51.0, 61.8) 631 55.9 (52.0, 59.8) 0.873
Note: IFA = iron‐folic acid; LNS = lipid‐based nutrient supplements; MMN = multiple micronutrient.
1The capsules group is the MMN and IFA capsule groups, combined.
2Values are percentage of respondents, adjusted for index child age, who indicated they held the specific perception (95% confidence interval).
3p values from logistic regression adjusted for index child age.
4IV, inadequate variation.
5p values from ordered logistic regression adjusted for index child age.
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who said they used a replacement for SQ‐LNS, 45.7% used another
supplement (multivitamins and multivitamin syrups were commonly
mentioned), 15.2% said they replaced SQ‐LNS with groundnuts (pea-
nuts) or groundnut paste, and 13.0% said they gave the index child milk
(Nido or Vitamilk) as a replacement.
When asked whether they noticed any differences in the foods
the index child preferred during the intervention compared with other
children, 65.5% said they did not observe any differences. Of the
30.7% who did note differences, 68.5% reported that the index child
preferred food that contained groundnuts, 23.6% indicated a prefer-
ence for sweet food and/or drinks, 9.0% said the child refused to eat
plain porridge, and 6.7% reported the child preferred rice or rice with
stew (SQ‐LNS was sometimes served to children mixed with porridge
or with stew). After the child stopped receiving SQ‐LNS at the end
of the intervention, 20.3% of mothers recalled differences in the index
child's food preferences compared with other children. Foods contain-
ing groundnuts was again the most commonly cited difference in food
preferences (50.9%), while a preference for sweet foods or drinks, a
preference for rice or rice and stew, refusal to eat plain porridge, and
a preference for fufu (boiled and pounded unripe plantain, cassava,
and/or yam, often eaten with soup) were also noted.
4 | DISCUSSION
In semiurban Ghana, both mothers and fathers generally had a positive
impression of supplementation, in general, for pregnant and lactating
women and for young children. A majority of mothers and fathers in
both the LNS group and the capsules group perceived that the
assigned supplements, in particular, positively impacted both the
mother and the index child, and they expected that the supplements
would continue to positively impact the index child's health and human
capital into the future. While much rarer, some mothers and fathers did
perceive that the intervention had negative impacts on the mother
and/or the index child. For both positive and negative impacts, there
were no differences in mothers' or fathers' perceptions between inter-
vention groups. This finding is consistent with results from a hypothet-
ical willingness‐to‐pay (WTP) study that was conducted within the
TABLE 4 Paternal perceptions by intervention group
Perception
LNS group Capsules Group1
N
Predicted percentage
(95% CI)2 N
Predicted percentage
(95% CI)2
p
value3
1) The assigned supplement had a positive impact on the mother during pregnancy 90 89.4 (83.1, 95.8) 166 89.4 (84.6, 94.1) .99
2) The assigned supplement had a positive impact on the mother during lactation 83 88.1 (81.1, 95.0) 160 84.4 (78.8, 90.0) .44
3) The assigned supplement had a negative impact on the mother during pregnancy 97 12.3 (5.8, 18.9) 182 12.1 (7.4, 16.8) .99
4) The assigned supplement had a negative impact on the mother during lactation 98 5.1 184 3.2 IV4
5) It is acceptable for children aged 6 months and 2 years to be given supplements 92 69.7 (60.3, 79.1) 174 67.2 (60.3, 74.2) .68
6) The assigned supplement had a positive impact on the index child 86 100 167 95.8 IV4
7) The assigned supplement had a negative impact on the index child 91 6.5 (1.4, 11.6) 175 10.3 (5.8, 14.8) .31
8) There are differences in the health of the index child compared with other
children
93 96.0 177 95.1 IV4
9) Supplement's role in child's cognitive development in the future 93 612 IV4
Negative impact 2.2 1.7
No impact 1.0 1.1
Positive impact 96.8 97.2
10) Supplement's role in child's performance in school in the future 87 590 IV4
Negative impact 1.2 0.6
No impact 4.6 1.2
Positive impact 94.3 98.3
11) Supplement's role in child's ability to do physical work in the future 91 617 IV4
Negative impact 0 0
No impact 0 1.2
Positive impact 100 98.8
12) Supplement's role in child's ability to earn money in the future 89 595 IV4
Negative impact 0 0
No impact 0 1.2
Positive impact 100 98.8
13) The intervention had an impact on other household members 100 63.0 (53.5, 72.4) 188 61.7 (54.8, 68.7) 0.84
Note: IFA = iron‐folic acid; LNS = lipid‐based nutrient supplements; MMN = multiple micronutrient.
1The capsules group is the MMN and IFA capsule groups combined.
2Values are percentage of respondents, adjusted for index child age, who indicated they held the specific perception (95% confidence interval).
3p values from logistic regression adjusted for index child age.
4IV, inadequate variation.
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same population during the randomised trial. WTP was elicited several
times during the trial, and there were no statistically significant differ-
ences in WTP for SQ‐LNS for the mother during pregnancy or postpar-
tum or for SQ‐LNS for her infant between the LNS and capsules
groups (Adams et al., 2017). Thus, although SQ‐LNS resulted in
increased birth size and height of the child at 18 months of age
(Adu‐Afarwuah et al., 2015; Adu‐Afarwuah et al., 2016), the differ-
ences in birth and growth outcomes may have been too small to be
perceptible to parents or may not have been valued enough by parents
to trigger relatively more positive perceptions of the impact of SQ‐LNS
than of nutrient capsules given only to the mother.
There are several sources of insight into maternal perceptions dur-
ing the intervention itself (compared with the retrospective or persis-
tent perceptions studied here). During the main trial in Ghana, in‐
depth interviews were conducted with a small subset (n = 30) of
women in the LNS group to explore adherence to study protocol and
acceptability of SQ‐LNS for maternal consumption during pregnancy
and the first 6 months postpartum (Klevor et al., 2016). Although sen-
sory attributes (taste, texture, smell, etc.) were important for adher-
ence, it was also common for women to cite expected health
benefits for themselves or their infants as a motivation for adherence.
Attributing nausea and/or vomiting to SQ‐LNS during pregnancy was a
commonly mentioned reason for nonadherence during the pregnancy
period. We also conducted surveys with all mothers at several time
points during the main trial to assess knowledge, attitudes, and prac-
tices. Exploratory analysis of select variables from those surveys
showed that when the index children were approximately 6 months
TABLE 5 Maternal perceptions of the index child's experience with
SQ‐LNS (LNS group only)1
Mothers
n/N2 Percent
(1) Maternal recollection of whether the index child
received SQ‐LNS when she/he turned 6 months
No 30/346 8.7
Does not know/remember 26/346 7.5
Yes 290/346 83.8
(2) There were times when the mother did not give
SQ‐LNS to the index child
No 179/290 61.7
Does not know/remember 9/290 3.1
Yes 102/290 35.2
(2.a) If yes, main reasons for not giving SQ‐LNS to
the index child
Mother forgot 41/102 40.2
Child refused food so could not give SQ‐LNS 24/102 23.5
Child refused food mixed with SQ‐LNS 23/102 22.6
Travelled 13/102 12.8
(3) Index child's reaction at the end of the
intervention
Child was indifferent 218/290 75.2
Does not know/remember 17/290 5.9
Other reaction 5/290 1.7
Child asked for SQ‐LNS 50/290 17.2
(3.a) If child asked for SQ‐LNS, frequency that index
child asked for SQ‐LNS in the first few weeks
after the end of the intervention
Less than once a week 13/50 26.0
About once a week 16/50 32.0
A few times a week 10/50 20.0
Every day 9/50 18.0
(4) After the end of the intervention, the mother
gave the index child something as a replacement
for SQ‐LNS
290
No 240/290 82.8
Does not know/remember 4/290 1.4
Yes 46/290 15.9
(4.a) If yes, replacements for SQ‐LNS given to index
child after the end of the intervention
Other supplements 21/46 45.7
Groundnuts/groundnut paste 7/46 15.2
Milk 6/46 13.0
Does not know/remember 7/46 15.2
(5) There was a difference in the foods the index
child liked to eat during the intervention
compared with other children
No 190/290 65.5
Does not know/remember 11/290 3.8
Yes 89/290 30.7
(5.a) Observed difference in index child's food
preferences during the intervention
Preferred food containing groundnuts 61/89 68.5
Preferred sweet foods/drinks 21/89 23.6
Refused to eat plain porridge 8/89 9.0
Preferred rice or rice and stew 6/89 6.7
(Continues)
TABLE 5 (Continued)
Mothers
n/N2 Percent
(6) There was a difference in the foods the index
child liked to eat after the end of the intervention
compared with other children
No 223/290 76.9
Does not know/remember 8/290 2.8
Yes 59/290 20.3
(6.a) Observed difference in index child's food
preferences after the end of the intervention
Preferred food containing groundnuts 30/59 50.9
Preferred sweet foods/drinks 11/59 18.6
Preferred rice or rice and stew 8/59 13.6
Refused to eat plain porridge 7/59 11.9
Preferred fufu3 6/59 10.2
Note: LNS = lipid‐based nutrient supplements; SQ‐LNS = Small‐quantity
lipid‐based nutrient supplements.
1Question 1 was asked to all mothers with an index child in the SQ‐LNS
group. Questions 2–6 were asked only to mothers who recalled that the
index child received SQ‐LNS.
2For main questions (1–6), values are number of mothers reporting each
response or the total number of mothers. For follow‐up questions (2.a–
6.a), values are the number of mothers who mentioned the specific
response or the total number of mothers in the follow‐up subgroup. Spe-
cific subresponses are reported when mentioned by ≥5% of mothers in
that subgroup.
3Fufu is boiled and pounded unripe plantain, cassava, and/or yam, often
eaten with soup.
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of age and then again at 18 months, almost all mothers (>98%) across
all intervention groups perceived that the index child was growing well.
Mothers in the LNS group only were also asked to describe anything
they had observed about their child after she or he had been consum-
ing SQ‐LNS for some time. Consistent with the findings from our
follow‐up assessment of perceptions, mothers predominately men-
tioned positive observations (the most commonly cited observations
at the child ages of both 6 and 18 months were that the index child
was active, eating well or more, gaining weight, sleeping well, and tak-
ing more breastmilk). To our knowledge, the only other study to assess
perceptions of SQ‐LNS was done in urban Haiti. In focus group discus-
sions conducted during the intervention, mothers were asked what
they liked about SQ‐LNS, and mothers indicated that they felt it had
positive impacts on their children's growth, health, and development
(Lesorogol, Jean‐Louis, Green, & Iannotti, 2015). These perceived
positive impacts were also among the most commonly mentioned in
Ghana.
This study had several limitations. First, the supplements were
provided as part of a randomised controlled efficacy trial, meaning
that households did not face any monetary costs to access the sup-
plements, and any time costs were minimal. If households had to reg-
ularly travel to a clinic to pick up supplements, for example, or faced
other out‐of‐pocket costs to access them, it is not known whether
parents' perceptions would be similar to those observed in the con-
text of an efficacy trial. Second, the low rate of successful follow‐up
with fathers may have introduced sample selection bias, and there-
fore all descriptions and analyses of fathers' perceptions are consid-
ered exploratory. Another limitation is that there were several small
differences in the characteristics of the follow‐up and lost to follow‐
up samples, which could have introduced bias, although the differ-
ences were small and our results did not change when we controlled
for these characteristics. Also, social desirability may have influenced
mothers' and fathers' reported perceptions, though the time gap
between the intervention and the follow‐up likely lessened this
potential issue. Finally, the retrospective nature of some of the ques-
tions, which required mothers and fathers to think back over several
years, may have introduced recall bias.
Study strengths include a relatively high rate of successful follow‐
up among targeted mothers as well as solicitation of both positive and
negative perceptions of the intervention and its effect on mothers and
their infants. Respondents were purposefully made to feel comfortable
about raising either positive or negative perceptions.
The results presented here suggest that similar populations would
likely be receptive to programs to deliver SQ‐LNS or micronutrient
capsules. The lack of differences between the LNS and capsules groups
in perceived benefits of the supplement received indicates that parents
viewed all of the nutritional supplements similarly, even though there
were demonstrable effects on child growth of SQ‐LNS. This implies
that social marketing or other efforts to explain the differences
between SQ‐LNS and other supplements might be necessary for pro-
grams that include SQ‐LNS. In addition, although perceptions of nega-
tive effects were uncommon, educational messages to address these
issues, such as nausea and/or vomiting during pregnancy, would be
useful. These messages could be delivered in a similar manner as the
information provided by study nurses when women complained of
negative effects during the intervention, for example, by ensuring that
women are aware of common symptoms of pregnancy and providing
them with strategies to help cope with them. Maternal accounts of
why doses of SQ‐LNS were sometimes skipped could be useful in
developing tools and techniques to improve compliance. We conclude
that overall, parents in this population generally reflected positively on
the iLiNS intervention in Ghana and felt that it had positive and lasting
impacts, particularly on the index child, which bodes well for future
programmatic efforts to improve maternal and child nutrition in such
populations.
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